Published in PLoS One on November 03, 2014
Optimizing Drug-Therapy in Patients 80 Years and Older | NCT00661310
The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol (2015) 0.84
A Systematic Review of Opioid and Benzodiazepine Misuse in Older Adults. Am J Geriatr Psychiatry (2016) 0.75
Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden. Drugs Real World Outcomes (2017) 0.75
Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med (2011) 8.75
Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med (2006) 7.02
Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med (2005) 5.52
Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet (2007) 5.20
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther (2008) 5.17
A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med (2009) 3.83
Polypharmacy and prescribing quality in older people. J Am Geriatr Soc (2006) 3.39
Deviation from prescribed drug treatment after discharge from hospital. Br Med J (1976) 3.35
Potentially inappropriate medication use among elderly home care patients in Europe. JAMA (2005) 3.13
Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05
Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev (2012) 2.67
Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc (2001) 2.61
Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). Dtsch Arztebl Int (2013) 2.06
Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol (2010) 2.04
START (screening tool to alert doctors to the right treatment)--an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing (2007) 1.80
Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc (2007) 1.69
Health status of UK care home residents: a cohort study. Age Ageing (2013) 1.41
Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing (2007) 1.32
Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol (2011) 1.30
Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig (2010) 1.26
Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing (2009) 1.08
Medication-related problems in the elderly : defining the issues and identifying solutions. Drugs Aging (2005) 1.07
"I just take what I am given": adherence and resident involvement in decision making on medicines in nursing homes for older people: a qualitative survey. Drugs Aging (2009) 1.07
Quality of drug prescribing in older patients: is there a problem and can we improve it? Intern Med J (2010) 1.04
A review of some statistical methods for covariance analysis of categorical data. Biometrics (1982) 1.03
Prescription and transcription errors in multidose-dispensed medications on discharge from hospital: an observational and interventional study. J Eval Clin Pract (2011) 0.86
Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ (2014) 6.87
Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort. Atherosclerosis (2014) 0.82
A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: secondary analysis of clinical trial data. BMJ Open (2015) 0.80
Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study. Eur Heart J (2015) 0.80
Pyrophosphate Stimulates Differentiation, Matrix Gene Expression and Alkaline Phosphatase Activity in Osteoblasts. PLoS One (2016) 0.76
Excessive dietary intake of vitamin A reduces skull bone thickness in mice. PLoS One (2017) 0.75
Reference intervals for parathyroid hormone for 70-year-old males and females: exclusion of individuals from the reference interval based on sex, calcium, diabetes, cardiovascular diseases or reduced kidney function has limited effects on the interval. Ann Clin Biochem (2014) 0.75
Medication Reviews Bridging Healthcare (MedBridge): Study protocol for a pragmatic cluster-randomised crossover trial. Contemp Clin Trials (2017) 0.75
Vitamin D and cognitive function: A Mendelian randomisation study. Sci Rep (2017) 0.75